Guo Y - Search Results

1

Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.

Li G, Wang G, Guo Y, Li S, Zhang Y, Li J, Peng B. Li G, et al. Among authors: guo y. World J Surg Oncol. 2020 Sep 19;18(1):249. doi: 10.1186/s12957-020-02025-0. World J Surg Oncol. 2020. PMID: 32950055 Free PMC article.

2

Differences in Immunological Landscape between EGFR-Mutated and Wild-Type Lung Adenocarcinoma.

Luo JW, Guo YH, Wu FY, Li XF, Sun XC, Wang JL, Zhou CC. Luo JW, et al. Dis Markers. 2021 Aug 26;2021:3776854. doi: 10.1155/2021/3776854. eCollection 2021. Dis Markers. 2021. PMID: 34484468 Free PMC article.

3

Prognostic significance of micropapillary and solid patterns in stage IA lung adenocarcinoma.

Peng B, Li G, Guo Y. Peng B, et al. Among authors: guo y. Am J Transl Res. 2021 Sep 15;13(9):10562-10569. eCollection 2021. Am J Transl Res. 2021. PMID: 34650727 Free PMC article.

4

A lncRNA signature of tumor-infiltrating macrophages is associated with prognosis and tumor immunity in lung adenocarcinoma.

Guo Y, Li G, Xu M, Peng B. Guo Y, et al. Comput Biol Med. 2022 Sep;148:105655. doi: 10.1016/j.compbiomed.2022.105655. Epub 2022 May 21. Comput Biol Med. 2022. PMID: 35715263 Free article.

5

Prognosis of lung cancer associated with cystic airspaces: A propensity score matching analysis.

Shen Y, Zhang Y, Guo Y, Li W, Huang Y, Wu T, Jiang G, Dai J. Shen Y, et al. Among authors: guo y. Lung Cancer. 2021 Sep;159:111-116. doi: 10.1016/j.lungcan.2021.07.003. Epub 2021 Jul 17. Lung Cancer. 2021. PMID: 34325317

6

Propensity-matched Comparison of VATS Left Upper Trisegmentectomy and Lobectomy.

Zhou B, Xu X, Dai J, Guo Y, Jin K, Zhu Y, Wang H, Jiang G. Zhou B, et al. Among authors: guo y. Ann Thorac Surg. 2022 Sep;114(3):1007-1014. doi: 10.1016/j.athoracsur.2021.07.057. Epub 2021 Aug 21. Ann Thorac Surg. 2022. PMID: 34428431

7

HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.

Song H, Li D, Wang X, Fang E, Yang F, Hu A, Wang J, Guo Y, Liu Y, Li H, Chen Y, Huang K, Zheng L, Tong Q. Song H, et al. Among authors: guo y. J Hematol Oncol. 2020 Mar 26;13(1):24. doi: 10.1186/s13045-020-00857-7. J Hematol Oncol. 2020. Retraction in: J Hematol Oncol. 2023 Aug 15;16(1):95. doi: 10.1186/s13045-023-01493-7 PMID: 32216806 Free PMC article. Retracted.

8

p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation.

Yang F, Hu A, Guo Y, Wang J, Li D, Wang X, Jin S, Yuan B, Cai S, Zhou Y, Li Q, Chen G, Gao H, Zheng L, Tong Q. Yang F, et al. Among authors: guo y. Mol Cancer. 2021 Sep 27;20(1):123. doi: 10.1186/s12943-021-01421-8. Mol Cancer. 2021. PMID: 34579723 Free PMC article.

9

Long Noncoding RNA NHEG1 Drives β-Catenin Transactivation and Neuroblastoma Progression through Interacting with DDX5.

Zhao X, Li D, Yang F, Lian H, Wang J, Wang X, Fang E, Song H, Hu A, Guo Y, Liu Y, Li H, Chen Y, Huang K, Zheng L, Tong Q. Zhao X, et al. Among authors: guo y. Mol Ther. 2020 Mar 4;28(3):946-962. doi: 10.1016/j.ymthe.2019.12.013. Epub 2020 Jan 11. Mol Ther. 2020. PMID: 31982037 Free PMC article.

10

Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation.

Yang F, Hu A, Li D, Wang J, Guo Y, Liu Y, Li H, Chen Y, Wang X, Huang K, Zheng L, Tong Q. Yang F, et al. Among authors: guo y. Mol Cancer. 2019 Nov 13;18(1):158. doi: 10.1186/s12943-019-1094-z. Mol Cancer. 2019. PMID: 31718709 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44,656 results

Search Page

Filters